• Directory of Taiwan

Pulmonary Drug Delivery Systems Market Size Analysis 2022: Competitive Insights, Leading Players, and Growth Opportunities by 2030

Report Ocean presents a new report on pulmonary drug delivery systems market size, share, growth, industry trends, and forecast 2030, covering various industry elements and growth trends helpful for predicting the market’s future.

The global pulmonary drug delivery systems market was US$ 53267.55 in 2021. The pulmonary drug delivery systems market is forecast to reach US$ 91,128.65 million by 2030, growing at a compound annual growth rate (CAGR) of 7% during the forecast period from 2022 to 2030.

Request To Download Sample of This Strategic Report:-

“Targeted drug delivery” means to direct drugs toward the target site. Pulmonary drug delivery is a targeted drug delivery system that delivers the drug moiety to the lower respiratory tract. As the name suggests, pulmonary drug delivery refers to the process of administering drugs through the lungs. Inhalation is a more effective method of administering drugs for asthma and chronic obstructive pulmonary disease. The delivery of pulmonary medicines offers immediate relief from asthmatic attacks and acute bronchitis. Pulmonary aerosols are a particular type of device that delivers drugs to the lungs.

Factors Influencing Market Growth

Increasing air pollution, a rise in prevalence of lung diseases such as asthma and chronic obstructive pulmonary disease, an increase in hospitals and diagnostic centers, and increased funding for pulmonary treatment drive the global pulmonary drug delivery systems market.

Developments in pulmonary drug delivery systems are forecast to contribute to the market’s growth. For example, in October 2018, Philips, a global leader in health technology, launched InnoSpire Go, a portable nebulizer that delivers medication in just four minutes, despite being small and lightweight.

The increase in awareness of pulmonary diseases and the growing number of hospitals and diagnostic centers are forecast to pose lucrative opportunities for growth in the global pulmonary drug delivery systems market during the forecast period.

The high cost of pulmonary drug delivery system devices and inaccurate diagnosis of respiratory diseases may slow down the global market growth during the forecast period.

Impact Analysis of COVID-19

The outbreak of COVID-19 had a positive impact on the global pulmonary drug delivery systems market. People with Chronic Obstructive Pulmonary Diseases and asthma were at higher risk of death from COVID-19. Globally, the COVID-19 pandemic has put tremendous pressure on healthcare systems, which has led to the need for diagnostic tools & treatment facilities. Many clinics and hospitals throughout the world restructured their operations to accommodate the increasing number of patients diagnosed with COVID-19. More hospitals had increased the number of diagnoses. The COVID-19 pandemic may have altered a patient’s response to respiratory symptoms, making them less likely to seek treatment. As a result, the global market has grown significantly.

Request To Download Sample of This Strategic Report:-

Regional Insights

In 2021, North America dominated the pulmonary drug delivery systems market and is forecast to continue dominating during the forecast period. The increasing prevalence of pulmonary diseases, the presence of key players in the manufacturing and development of pulmonary disease drugs, the growth of hospitals and diagnostic centers, and government initiatives to improve the treatment of pulmonary disease in the region all contribute to this growth.

Asia-Pacific is forecast to grow at the fastest CAGR during the forecast period. Due to the increasing prevalence of pulmonary diseases, the need for pulmonary drug delivery, and the development of different healthcare foundations in the region.

Leading Competitors

The leading prominent companies profile in the global pulmonary drug delivery systems market are:

AstraZeneca plc

Boehringer Ingelheim GmbH

GlaxoSmithKline plc

Novartis AG

Koninklijke Philips N.V.

3M company

Janssen (Johnson & Johnson)

Clement Clarke International

Briggs Healthcare


Other Prominent Players

Scope of the Report

The global pulmonary drug delivery systems market segmentation focuses on Product, Application, Distribution Channel, and Region.

Segmentation based on Product

Dry powder inhaler

Single-dose inhaler

Multi-dose inhaler

Metered-dose inhaler

Manually-Actuated Pressurized Inhaler

Breath-Actuated Pressurized Inhaler


Jet Nebulizer

Ultrasonic Wave Nebulizer

Vibrating Mesh Nebulizer

Segmentation based on Application


Chronic Obstructive Pulmonary Disease (COPD)

Cystic Fibrosis


Segmentation based on Distribution Channel

Retail Pharmacies

Hospital Pharmacies


Get a Sample PDF copy of the report:-

Segmentation based on Region

North America

The U.S.




Western Europe

The UK





Rest of Western Europe

Eastern Europe



Rest of Eastern Europe

Asia Pacific




Australia & New Zealand


Rest of Asia Pacific

Middle East & Africa (MEA)


Saudi Arabia

South Africa

Rest of MEA

South America



Rest of South America

What are the aspects of this report that relate to regional analysis?

The report’s geographical regions include North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
The report provides a comprehensive analysis of market trends, including information on usage and consumption at the regional level.
Reports on the market include the growth rates of each region, which includes their countries, over the coming years.
How are the key players in the market assessed?
This report provides a comprehensive analysis of leading competitors in the market.
The report includes information about the key vendors in the market.
The report provides a complete overview of each company, including its profile, revenue generation, cost of goods, and products manufactured.
The report presents the facts and figures about market competitors, alongside the viewpoints of leading market players.
A market report includes details on recent market developments, mergers, and acquisitions involving the key players mentioned.

Access full Report Description, TOC, Table of Figure, Chart, etc.-

About Report Ocean:

We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is a ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:
Report Ocean:
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES Tel: +1 888 212 3539 (US – TOLL FREE)